Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Cepharanthine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,012Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    PharmaTher's Sairiyo OK'd To Start Phase 1 Trial Of PD-001
    PharmaTher's Sairiyo OK'd To Start Phase 1 Trial Of PD-001

    19 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/19/2932052/0/en/PharmaTher-s-Sairiyo-Therapeutics-Receives-Approval-to-Initiate-a-Phase-1-Human-Clinical-Trial-of-PD-001-Reformulated-Cepharanthine.html

    GLOBENEWSWIRE
    19 Aug 2024
    Share Share
    PharmaTher's Sairiyo Submits CTA For Phase 1 Reformulated Cepharanthine Study
    PharmaTher's Sairiyo Submits CTA For Phase 1 Reformulated Cepharanthine Study

    15 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/15/2882391/0/en/PharmaTher-s-Sairiyo-Therapeutics-Submits-Clinical-Trial-Application-for-Phase-1-Study-of-Patented-Reformulated-Cepharanthine.html

    GLOBENEWSWIRE
    15 May 2024
    Share Share
    PharmaTher's Sairiyo Readies Reformulated Cepharanthine Phase 1
    PharmaTher's Sairiyo Readies Reformulated Cepharanthine Phase 1

    01 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/01/2873176/0/en/PharmaTher-s-Sairiyo-Therapeutics-Completes-Clinical-and-Regulatory-Package-for-Phase-1-Study-of-Patented-Reformulated-Cepharanthine.html

    GLOBENEWSWIRE
    01 May 2024
    Share Share